Clinical Efficacy and Health Economic Evaluation of an Intelligent Diagnostic and Treatment Model
ConditionInsomnia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZan Wang
About this trial
The purpose of this study is to evaluate the clinical and cost-effectiveness of an intelligent therapy based on digital cognitive behavioral therapy for insomnia disorders
Eligibility criteria
Qualifiers
(1) Clinical diagnosis of insomnia disorder; (2) Cooperate to complete the questionnaire surveys.
Disqualifiers
(1) Current use of central nervous system stimulants; (2) Use of analgesics, theophylline preparations, steroid medications; (3) Alcohol abuse or regular alcohol intake; (4) Diagnosis of other sleep disorders (e.g., obstructive sleep apnea, rapid eye movement sleep behavior disorder, restless legs syndrome) ; (5) Sleep disorders secondary to organic diseases (e.g., epilepsy, diabetes, renal failure).
Trial design
Treatments tested in this trial
- Intelligent Diagnostic and Treatment Model
- Traditional treatment
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Zan Wang
Lead sponsor
The First Hospital of Jilin University
Sponsor institution
Source ClinicalTrials.gov